ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 274 filers reported holding ARRAY BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $17,412,000 | +15.8% | 714,190 | -32.3% | 0.02% | 0.0% |
Q4 2018 | $15,032,000 | -51.3% | 1,054,884 | -48.1% | 0.02% | +10.5% |
Q3 2018 | $30,878,000 | +25.9% | 2,031,400 | +39.0% | 0.02% | -38.7% |
Q2 2018 | $24,522,000 | +4.1% | 1,461,406 | +1.3% | 0.03% | 0.0% |
Q1 2018 | $23,550,000 | +39.4% | 1,443,036 | +9.4% | 0.03% | +40.9% |
Q4 2017 | $16,891,000 | +7.8% | 1,319,624 | +3.6% | 0.02% | +4.8% |
Q3 2017 | $15,673,000 | +46.9% | 1,274,223 | -0.0% | 0.02% | +40.0% |
Q2 2017 | $10,669,000 | +42.0% | 1,274,728 | +51.6% | 0.02% | +36.4% |
Q1 2017 | $7,516,000 | -58.1% | 840,718 | -58.8% | 0.01% | -60.7% |
Q4 2016 | $17,936,000 | +34.3% | 2,040,451 | +3.1% | 0.03% | +27.3% |
Q3 2016 | $13,357,000 | +89.7% | 1,978,792 | +0.0% | 0.02% | +83.3% |
Q2 2016 | $7,042,000 | +24.7% | 1,978,140 | +3.3% | 0.01% | +20.0% |
Q1 2016 | $5,647,000 | +7.0% | 1,914,146 | +53.0% | 0.01% | 0.0% |
Q4 2015 | $5,278,000 | +465.7% | 1,250,688 | +511.2% | 0.01% | +400.0% |
Q3 2015 | $933,000 | -36.7% | 204,628 | 0.0% | 0.00% | -33.3% |
Q2 2015 | $1,475,000 | +2.9% | 204,628 | +5.2% | 0.00% | 0.0% |
Q1 2015 | $1,434,000 | +70.3% | 194,510 | +9.3% | 0.00% | +50.0% |
Q4 2014 | $842,000 | +32.6% | 177,963 | 0.0% | 0.00% | +100.0% |
Q3 2014 | $635,000 | -21.8% | 177,963 | 0.0% | 0.00% | -50.0% |
Q2 2014 | $812,000 | -78.9% | 177,963 | -78.3% | 0.00% | -75.0% |
Q1 2014 | $3,852,000 | -27.4% | 819,582 | -22.6% | 0.01% | -33.3% |
Q4 2013 | $5,303,000 | -16.1% | 1,058,402 | +4.1% | 0.01% | -25.0% |
Q3 2013 | $6,323,000 | +37.9% | 1,016,622 | +0.6% | 0.02% | +33.3% |
Q2 2013 | $4,586,000 | – | 1,010,116 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|